There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Benitec Biopharma (BNTC – Research Report) and Moderna (MRNA – Research Report) with bullish sentiments. Benitec Biopharma (BNTC) In a report released today, Silvan Tuerkcan from JMP Securities maintained a Buy rating on Benitec Biopharma, with a price target of $4.00. The company's shares closed last Thursday at $0.16, close to its 52-week low of $0.13. According to TipRanks.
https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-benitec-biopharma-bntc-moderna-mrna?utm_source=advfn.com&utm_medium=referral